Adaptive Biotechnologies Corporation (ADPT) vs LifeStance Health Group, Inc. (LFST)

A side-by-side comparison of Adaptive Biotechnologies Corporation and LifeStance Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADPT vs LFST

growth of $100 · dividends reinvested · last 5y
ADPT -21.3% (-4.7%/yr)LFST -44.2% (-11.0%/yr)ADPT compounded faster over this window
050100Start $10020222023202420252026$79$56
ADPT LFST

ADPT vs LFST: by the numbers

  • •LFST is the larger company ($4.63B vs $4.51B market cap).
  • •LFST is profitable (3.19% net margin) while ADPT runs a net loss (-20.73%).
  • •LFST grew revenue faster over the past five years (24.79% vs 18.22% CAGR).

Metrics side by side

Valuation

MetricADPTLFST
P/E ratioN/A92.14
Forward P/EN/A74.44
P/S ratio14.652.92
P/B ratio31.583.14
EV / EBITDAN/A34.66
FCF yieldN/A3.75%

Profitability

MetricADPTLFST
Gross margin75.44%33.56%
Operating margin-20.62%4.95%
Net margin-20.73%3.19%
ROE-44.68%3.43%
ROIC-6.67%3.03%

Growth (annualized)

MetricADPTLFST
Revenue CAGR (5Y)18.22%24.79%
Total return CAGR (5Y)-1.77%-1.46%

Frequently asked

Which has grown faster, ADPT or LFST?
Over the past five years, LFST grew revenue faster — ADPT at a 18.22% CAGR versus LFST at 24.79%.
Is ADPT or LFST more profitable?
LFST runs the higher net margin — ADPT at -20.73% versus LFST at 3.19%.
How have ADPT and LFST total returns compared?
Over the past 5 years, ADPT delivered -1.77% and LFST delivered -1.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.